The distribution of the extrachromosomal DNA molecules in early lung cancer

Author:

Fang Jianfei1,Ying Lisha2,Ma Zhengxiao3,Yang Ying4,Zhu Rui1,Su Dan3

Affiliation:

1. Zhejiang Cancer Hospital, Chinese Academy of Sciences

2. Zhejiang Cancer Institute, Zhejiang Cancer Hospital, Chinese Academy of Sciences

3. Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital)

4. Zhejiang Chinese Medicine University

Abstract

Abstract Background Lung cancer (LC) is a cancer with high mortality worldwide. Research on the distribution and nature of extrachromosomal DNA molecules (EcDNAm) in early LC is scarce. Methods After removing linear DNA and mitochondrial circular DNA, EcDNAm were extracted from two paired LC tissue samples and amplified using rolling circle amplification. High throughput extrachromosomal DNA or RNA sequencing and bioinformatics analysis were used to explore the distribution and nature of the EcDNAm. To learn more about the role of oncogenes with large EcDNAm sizes, gene onology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed. Results RNA sequencing results revealed the significant difference in some genes between tumor and corresponding normal samples. At the same time, obvious distinctions were observed between relapsed and non-relapsed tumor samples. The nature of the EcDNAm was comparable between LC samples and matched normal samples. Compared with the matched normal samples, the number of EcDNAm with longer size (EcDNA), which contained driver oncogenes, was relatively high. The majority of EcDNA in this study was mainly focused on the tumor samples. Enrichment analysis of the cancer samples revealed enrichment in biological processes, such as positive regulation of protein localization, axon development and in utero embryonic development. Conclusions This study demonstrated the universality of the distribution and described the nature of EcDNAm in early LC. Moreover, our work fills the investigation of the EcDNAm gap and future studies should focus on the application of EcDNA as a potential biomarker in patients with early LC.

Publisher

Research Square Platform LLC

Reference28 articles.

1. Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions;Teixeira VH;Nat Med,2019

2. Cancer statistics in China, 2015;Chen W;Cancer J Clin,2016

3. Global cancer statistics, 2012;Torre LA;Cancer J Clin,2015

4. [Effect of Adjuvant Chemotherapy on DFS for Patients with Stage I NSCLC]. Zhongguo fei ai za zhi = Chinese;Peng S;J lung cancer,2017

5. Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?;Remon J;BMC Med,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3